Dr. Keval V. Patel, MD

Dr. Patel practices at Monmouth Cardiology Associates in Eatontown, New Jersey.

Dr. Patel's NPI, 1023362787, was assigned on November 2, 2012. Dr. Patel holds New Jersey license 25MA09697900.

Dr. Patel's primary practice is Monmouth Cardiology Associates, at 11 Meridian Rd, Eatontown, NJ 07724 in Monmouth County. The practice phone is (732) 663-0300.

Dr. Patel's primary practice is Monmouth Cardiology Associates in Eatontown, New Jersey. Dr. Patel is also affiliated with Robert Wood Johnson University Hospital. The medical group on file is Monmouth Cardiology Associates. Dmand AI also links Dr. Patel to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Patel is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Patel is licensed in New Jersey.

CMS data shows 3,573 Medicare services from Dr. Patel across 23 procedure codes in 2024, for 934 Medicare patients. Medicare paid $320,930 for them.

CMS counts 934 Medicare patients who saw Dr. Patel in 2024. The largest group is 75 to 84, with 366 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 65, with 51% women.

In 2024, Dr. Patel wrote 3,433 Medicare Part D claims for 573 patients. 83% of them were for generic drugs. CMS names the drug for 3,137 of them, across 43 drugs with 11 or more claims each, at $614,954 in total drug cost. In 2023, CMS named 3,496 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Patel for performance year 2024, reported through an alternative payment model (APM). Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Patel, published from 2015 to 2023. 2022 was the busiest year, with 2. Dr. Patel has published most often in Cureus. Dr. Patel's most frequent co-authors are Paul J. Hauptman, MD, Surya Kiran Aedma, MD and Ghulam Mustafa Aftab, MD.

CMS Open Payments shows 476 general payments to Dr. Patel from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Boston Scientific Corporation paid the most, $1,091.